Days alive and free as an alternative to a mortality outcome in pivotal vasopressor and septic shock trials
- 1 October 2018
- journal article
- research article
- Published by Elsevier in Journal of Critical Care
- Vol. 47, 333-337
Abstract
No abstract availableKeywords
Funding Information
- Canadian Institutes of Health Research (MCT 44152)
- European Society of Intensive Care
- the French Ministry of Health (AOM 97123)
This publication has 10 references indexed in Scilit:
- Surviving Sepsis Campaign: International Guidelines for Management of Sepsis and Septic Shock: 2016Critical Care Medicine, 2017
- Short-Term Organ Dysfunction Is Associated With Long-Term (10-Yr) Mortality of Septic ShockCritical Care Medicine, 2016
- Understanding and Improving Clinical Trial Outcome Measures in Acute Respiratory FailureAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Heterogeneity in the Definition of Mechanical Ventilation Duration and Ventilator-Free DaysAmerican Journal of Respiratory and Critical Care Medicine, 2014
- Mortality Related to Severe Sepsis and Septic Shock Among Critically Ill Patients in Australia and New Zealand, 2000-2012JAMA, 2014
- Severe Sepsis and Septic ShockNew England Journal of Medicine, 2013
- Comparison of Dopamine and Norepinephrine in the Treatment of ShockNew England Journal of Medicine, 2010
- Vasopressin versus Norepinephrine Infusion in Patients with Septic ShockNew England Journal of Medicine, 2008
- Norepinephrine plus dobutamine versus epinephrine alone for management of septic shock: a randomised trialThe Lancet, 2007
- Statistical evaluation of ventilator-free days as an efficacy measure in clinical trials of treatments for acute respiratory distress syndromeCritical Care Medicine, 2002